Anygen Co., Ltd.

A196300

KR7196300008

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-30 EDT			5-day change	1st Jan Change
14,100 ^KRW	+0.50%		-1.05%	-4.08%

04-05	Anygen Co., Ltd. announced that it has received KRW 999.98709 million in funding	CI
03-28	Anygen Co., Ltd. announced that it expects to receive KRW 999.98709 million in funding	CI

KDB Capital Corp. acquired 8.89% stake in ANYGEN Co. Ltd..

December 11, 2016

KDB Capital Corp. acquired 8.89% stake in ANYGEN Co. Ltd. (KOSDAQ:A196300) on December 12, 2016. KDB Capital acquired 0.33 million shares. KDB Capital Corp. completed the acquisition of 8.89% stake in ANYGEN Co. Ltd. (KOSDAQ:A196300) on December 12, 2016.

Latest news about Anygen Co., Ltd.

Anygen Co., Ltd. announced that it has received KRW 999.98709 million in funding	04-04	CI
Anygen Co., Ltd. announced that it expects to receive KRW 999.98709 million in funding	03-27	CI
ANYGEN Co.,Ltd announced that it has received KRW 15 billion in funding from Atinum Investment Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm	18-06-07	CI
ANYGEN Co.,Ltd announced that it expects to receive KRW 15 billion in funding from Atinum Investment Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm	18-06-04	CI
An unknown buyer acquired 5.6% stake in ANYGEN Co.,Ltd from KDB Capital Corp.	17-02-07	CI
KDB Capital Corp. acquired 8.89% stake in ANYGEN Co. Ltd..	16-12-11	CI
ANYGEN Co. Ltd. has completed an IPO in the amount of KRW 12.6 billion.	16-12-06	CI
ANYGEN Co. Ltd. has filed an IPO.	15-08-12	CI

Chart Anygen Co., Ltd.

Duration

Period

More charts

Company Profile

ANYGEN CO., LTD. is a Korea-based company mainly engaged in manufacture and distribution of peptides. The Company's products mainly consist of leuprorelin acetate, desmopressin acetate, and contract manufacturing organization (CMO) peptides, which are used for pharmaceuticals; custom peptides, which is used for research, and argireline, which is used for cosmetics. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANYGEN CO., LTD.	-4.08%	61.18M
ELI LILLY AND COMPANY	+56.86%	823B
NOVO NORDISK A/S	+44.94%	641B
JOHNSON & JOHNSON	-6.57%	352B
MERCK & CO., INC.	+17.32%	324B
ABBVIE INC.	+9.94%	301B
ASTRAZENECA PLC	+15.47%	241B
ROCHE HOLDING AG	+1.27%	223B
NOVARTIS AG	+12.98%	218B
AMGEN INC.	+7.98%	167B